Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001183740-22-000182
Filing Date
2022-11-23
Accepted
2022-11-23 17:21:40
Documents
3
Period of Report
2022-11-23

Document Format Files

Seq Description Document Type Size
1 f6k-20221123drug.htm 6-K 5130
2 NEWS RELEASE ex991-20221123drug.htm EX-99.1 10012
3 ex99120221123drug_1.jpg GRAPHIC 2115
  Complete submission text file 0001183740-22-000182.txt   19159
Mailing Address 19 VESTRY STREET NEW YORK NY 10013
Business Address 19 VESTRY STREET NEW YORK NY 10013 6474072515
BRIGHT MINDS BIOSCIENCES INC. (Filer) CIK: 0001827401 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: 6-K | Act: 34 | File No.: 001-40997 | Film No.: 221417140
SIC: 2834 Pharmaceutical Preparations